+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zaleplon"

Insomnia Global Market Report 2024 - Product Thumbnail Image

Insomnia Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Sleep Disorder Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Sleep Disorder Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Sleep Disorder Treatment Drugs Markets in China - Product Thumbnail Image

Sleep Disorder Treatment Drugs Markets in China

  • Report
  • February 2024
  • 227 Pages
  • China
From
Sleep Disorder Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Sleep Disorder Treatment Drugs Industry Forecasts - China Focus

  • Report
  • February 2024
  • 114 Pages
  • China
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Zaleplon is a sedative-hypnotic drug used to treat insomnia. It is classified as a Central Nervous System (CNS) drug, and is a member of the pyrazolopyrimidine class of drugs. Zaleplon works by binding to the GABA-A receptor, which increases the activity of the neurotransmitter GABA, resulting in sedation and relaxation. It is typically prescribed for short-term use, as it can cause dependence and tolerance if used for longer periods of time. Zaleplon is available in both generic and brand-name formulations, and is sold in the United States, Canada, and Europe. It is typically taken orally, and is available in capsule and tablet form. The market for Zaleplon is highly competitive, with several major pharmaceutical companies competing for market share. Some of the companies in the market include Sunovion Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more